# Dalbavancin

NDC: 70069-830
Generic name: Dalbavancin
Labeler / Manufacturer: Somerset Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260727

FDA application: ANDA219604

## Active ingredients

- DALBAVANCIN HYDROCHLORIDE: 500 mg/25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-830"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-830
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4c0bd0f-03c2-4ce5-bcc2-b58f21ce75c1